We narrowed to 1,808 results for: ABE8e
-
Plasmid#179089Purposenuclease Cas expressionDepositorInsertCas9-VRER
UseCRISPR and LentiviralAvailable sinceJan. 19, 2022AvailabilityAcademic Institutions and Nonprofits only -
pRDA_155
Plasmid#179088Purposenuclease Cas expressionDepositorInsertCas9-VQR
UseCRISPR and LentiviralAvailable sinceJan. 19, 2022AvailabilityAcademic Institutions and Nonprofits only -
pRDA_154
Plasmid#179087Purposenuclease Cas expressionDepositorInsertxCas9-3.7
UseCRISPR and LentiviralAvailable sinceJan. 19, 2022AvailabilityAcademic Institutions and Nonprofits only -
pRDA_153
Plasmid#179086Purposenuclease Cas expressionDepositorInsertevoCas9
UseCRISPR and LentiviralAvailable sinceJan. 19, 2022AvailabilityAcademic Institutions and Nonprofits only -
pRDA_152
Plasmid#179085Purposenuclease Cas expressionDepositorInserteCas9-1.1
UseCRISPR and LentiviralAvailable sinceJan. 19, 2022AvailabilityAcademic Institutions and Nonprofits only -
pRDA_151
Plasmid#179084Purposenuclease Cas expressionDepositorInsertCas9-HF
UseCRISPR and LentiviralAvailable sinceJan. 19, 2022AvailabilityAcademic Institutions and Nonprofits only -
E1_pENTR_L1-L4_NI_G1397-DddtoxA-C
Plasmid#171726PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceSept. 7, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E3_pENTR_L3-L2_NG_G1397-DddtoxA-C
Plasmid#171734PurposeptpTALECD vector assembly, Entry clone 1 with attL2 and L3DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E3_pENTR_L3-L2_NG_G1397-DddtoxA-N
Plasmid#171735PurposeptpTALECD vector assembly, Entry clone 1 with attL2 and L3DepositorInsertC- and N termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E1_pENTR_L1-L4_NI_G1397-DddtoxA-N
Plasmid#171727PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E1_pENTR_L1-L4_NN_G1397-DddtoxA-N
Plasmid#171731PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E2_pENTR_R4R3_T CTP
Plasmid#171736PurposeptpTALECD vector assembly, Entry clone 2 with attR4 and R3DepositorInsertA terminator of Arabidopsis heat shock protein, RPS5A promoter, and RecA1 plastid targeting signal
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E1_pENTR_L1-L4_NN_G1397-DddtoxA-C
Plasmid#171730PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 27, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
Lenti U6-HBG site1-EF1alpha-UGI-P2A-GFP
Plasmid#157951PurposeLentiviral expression of HBG site 1 sgRNADepositorInsertLenti U6-HBG site1-EF1alpha-UGI-P2A-GFP
UseCRISPR and LentiviralExpressionMammalianAvailable sinceDec. 4, 2020AvailabilityAcademic Institutions and Nonprofits only -
Lenti U6-HBG site1-EF1alpha-UGI-P2A-GFP
Plasmid#157951PurposeLentiviral expression of HBG site 1 sgRNADepositorInsertLenti U6-HBG site1-EF1alpha-UGI-P2A-GFP
UseCRISPR and LentiviralExpressionMammalianAvailable sinceDec. 4, 2020AvailabilityAcademic Institutions and Nonprofits only -
BE3-hA3A-Y130F
Plasmid#132945PurposeGene editing. See Gene/Insert section of plasmid page for targeting sequence cloned into this plasmid.DepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertBE3-hA3A(Y130F)
UseCRISPR; Base editorExpressionMammalianMutationBE3-hA3A(Y130F)Available sinceNov. 24, 2020AvailabilityAcademic Institutions and Nonprofits onlyCited by -
BE3-hA3A-Y130F
Plasmid#132945PurposeGene editing. See Gene/Insert section of plasmid page for targeting sequence cloned into this plasmid.DepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertBE3-hA3A(Y130F)
UseCRISPR; Base editorExpressionMammalianMutationBE3-hA3A(Y130F)Available sinceNov. 24, 2020AvailabilityAcademic Institutions and Nonprofits onlyCited by -
S1 1029 CP ABEMax strategy 1
Plasmid#135357PurposeExpression of circular permutant of nSpyCas9 at amino acid position 1029 encoding ABEMax (wildtype Tada monomer coupled with evolved Tada monomer) at the N-terminusDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertABEMax-nSpyCas9 aa 1029
UseCRISPRExpressionMammalianMutationWTAvailable sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
miniABEMax V82G wt
Plasmid#135362PurposeExpression of nSpyCas9 with N-terminal miniABEMax (V82G)DepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertminiABEMax nSpyCas9
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
miniABEMax V82G nSaCas9
Plasmid#135365PurposeExpression of SaCas9 nickase (D10A) with single evolved TadA monomer (ABEMax) with a V82G substitutionDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertminiABEMax V82G nSaCas9
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only